Metabotropic glutamate 5 receptors regulate sensitivity to ethanol in mice

The International Journal of Neuropsychopharmacology
M K BirdAndrew J Lawrence

Abstract

The metabotropic glutamate receptor 5 (mGlu5) has been implicated in ethanol- and drug-seeking behaviours in rodent studies. Here we examine a number of ethanol-related behavioural assays in mice lacking mGlu5 and wild-type littermates. In a two-bottle free-choice paradigm, mGlu5-deficient mice consumed less ethanol with a reduced preference compared to wild-type mice. Indeed, mGlu5-deficienct mice were ethanol-avoiding at both concentrations of ethanol proffered (5% and 10% v/v). However, there was no difference in the rate of hepatic ethanol and acetaldehyde metabolism between genotypes and consumption of saccharin was similar. In a conditioned place preference study, mGlu5-deficient mice displayed a place preference for ethanol when conditioned with a low dose (1g/kg) of ethanol. Thus, while mGlu5-deficient mice consume less ethanol (with a reduced preference) than wild-type mice, this is not apparently related to impaired hepatic metabolism or a lack of reward from ethanol. Rather, we provide evidence that deletion of the mGlu5 receptor increases sensitivity to centrally mediated effects of ethanol.

References

Jan 1, 1997·Annual Review of Pharmacology and Toxicology·P J Conn, J P Pin
Sep 3, 1998·European Journal of Pharmacology·M El-GhundiB F O'Dowd
Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M StortoM Vairetti
Feb 13, 2001·Pharmacology, Biochemistry, and Behavior·C L CunninghamD K Grandy
Oct 5, 2001·Nature Reviews. Neuroscience·S E Hyman, R C Malenka
Jan 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Pia BäckströmRainer Spanagel
May 4, 2004·Trends in Pharmacological Sciences·Paul J Kenny, Athina Markou
Nov 19, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joyce Besheer, Clyde W Hodge
Feb 26, 2005·Psychopharmacology·James N C Kew, John A Kemp
Aug 27, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jennifer Lynn ShortAndrew John Lawrence
Jan 27, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Carla Sanchis-SeguraRainer Spanagel
Apr 1, 2006·Alcoholism, Clinical and Experimental Research·Jennifer Lynn ShortAndrew John Lawrence
Apr 26, 2006·Alcoholism, Clinical and Experimental Research·Christina M GremelChristopher L Cunningham
Sep 12, 2006·Addiction Biology·John C CrabbeGeorge F Koob
Nov 23, 2006·Alcoholism, Clinical and Experimental Research·Janel M Boyce-RustayAndrew Holmes
Apr 25, 2007·Alcoholism, Clinical and Experimental Research·Rosanna MooreAndrew J Lawrence
Dec 12, 2007·Alcoholism, Clinical and Experimental Research·Amanda C Sharko, Clyde W Hodge

❮ Previous
Next ❯

Citations

Sep 3, 2013·Psychopharmacology·Andrew HolmesJohn H Krystal
Mar 23, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Youssef SariRichard L Bell
Jul 27, 2010·Pharmacogenetics and Genomics·Chris DowningThomas E Johnson
Dec 15, 2010·PloS One·Christopher M OlsenDanny G Winder
Mar 1, 2014·Drug and Alcohol Dependence·Michael K BirdAndrew J Lawrence
Dec 24, 2013·Pharmacology & Therapeutics·Lucyna Pomierny-ChamiołoMałgorzata Filip
Oct 31, 2015·Addiction Biology·Manuela EisenhardtAinhoa Bilbao
Mar 30, 2011·Pharmacology, Biochemistry, and Behavior·Jhodie R Duncan, Andrew J Lawrence
Nov 7, 2009·Trends in Pharmacological Sciences·Michael K Bird, Andrew J Lawrence
Aug 19, 2008·Neuroscience Letters·Silvânia Maria Mendes VasconcelosGlauce Socorro de Barros Viana
May 30, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Brandon M Fritz, Stephen L Boehm
Nov 26, 2015·Frontiers in Neuroscience·Manoranjan S D'Souza
Jun 5, 2012·Wiley Interdisciplinary Reviews. Membrane Transport and Signaling·Richard M Cleva, M Foster Olive
Aug 8, 2014·Frontiers in Neuroscience·Youssef Sari
Apr 7, 2018·Alcoholism, Clinical and Experimental Research·Marc A Schuckit
Jun 24, 2009·The International Journal of Neuropsychopharmacology·Michael K BirdAndrew J Lawrence
Jan 11, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jérémie NeastaSami Ben Hamida
Feb 15, 2020·Alcoholism, Clinical and Experimental Research·George Kunos
Aug 2, 2019·Brain Sciences·Chelsea R KastenTiffany A Wills
Sep 3, 2019·Cell Metabolism·Won-Mook ChoiWon-Il Jeong
Dec 18, 2020·Pharmacological Reviews·Antonio InserraGabriella Gobbi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.